Matt’s Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jul 29, 2021)
Matt's Act
This bill limits the amount that private health insurance plans may charge plan holders for insulin drugs to a maximum of $20, or $0 for high deductible plans; pharmacies may charge uninsured individuals the average price of such drugs after deducting any rebates and discounts provided by drug manufacturers, plus limited additional charges for distributing and dispensing costs.
What just happenedJul 30, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJul 29, 2021
- Jul 30, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 29, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Education and the Workforce Committee - Jul 29, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jul 29, 2021IntroReferralIntro-H
Introduced in House
- Jul 29, 2021IntroReferral1000
Introduced in House